Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
GeneExcel
company
About
GeneExcel is engaged in the R&D and deployment of liposome technologies for the treatment of cancer, HIV, and cardiovascular diseases.
- 1 - 10
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- $700K
- Industries
- Biotechnology,Manufacturing
- Founded date
- Jan 1, 2002
- Number Of Employee
- 1 - 10
- Operating Status
- Active
GeneExcel engages in the discovery, design, development, and deployment of liposome technologies. Its technologies are utilized for the treatment of cancer, cardiovascular diseases, and HIV-1-related diseases. The company also provides contract manufacturing services for customized systemic liposome products. Gene Excel was founded in 2002 and is based in Houston, Texas.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$700K
GeneExcel has raised a total of
$700K
in funding over 2 rounds. Their latest funding was raised on
Mar 15, 2005 from a Series A round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Mar 15, 2005 | Series A | $700K | 1 |
ITX International Holdings
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
1
1
GeneExcel is funded by 1 investors.
ITX International Holdings
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
ITX International Holdings
|
Yes | Series A |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
